Navigation Links
Drug Production in Afghanistan: A Challenge for the International Community
Date:5/24/2010

MOSCOW, May 24 /PRNewswire-USNewswire/ -- The international forum "Drug Production in Afghanistan: A Challenge for the International Community" will be held in Moscow on June 9 and 10, 2010, at Russia's initiative.

Heads of the key global drug control agencies and leading drug enforcement experts will gather in Moscow for a conference initiated by the Russian News & Information Agency RIA Novosti. The idea is supported by Russia's State Anti-Drug Committee, the Council for Foreign and Defense Policy and the Institute of Demography, Migration and Regional Development.

"Drug production in Afghanistan and the trafficking that follows have become so acute a problem that it requires leading figures in drug control agencies and the expert community to come together and discuss joint solutions. This problem must be resolutely confronted by the international community and a broad antidrug coalition formed," said Viktor Ivanov, Chairman of the State Anti-Drug Committee of the Russian Federation.

According to Russia's Federal Service for Drug Control, about 100,000 people worldwide, including up to 30,000 Russians, die each year as a result of opiates produced in Afghanistan, more than the number of those killed by the Hiroshima bomb. Production of opium-based drugs has doubled in the world over the past decade. With annual production standing at 7 billion doses, about 90% of the total, heroin dominates the global drugs market. It is turning the world, countries throughout Europe and Asia, Russia included, into a drug-ridden breeding ground for crime. The $65 billion dollars of drug money is destabilizing the young democracies of Central Asia, through which the main drug routes run, and hinders the process of normalization in Afghanistan.

Participants in the Moscow forum will try to determine the points of shared interest between all concerned parties, creating a common foundation for the struggle against drug production and trafficking.

The forum will be attended by the heads of drug control and law-enforcement agencies from many countries, statesmen, politicians, experts, journalists and representatives of the UN, the Collective Security Treaty Organization (CSTO), NATO, the Shanghai Cooperation Organization (SCO) and other international organizations.

It will be held in the Conference Center of the Swissotel Krasnye Holmy. Press accreditation information will be available later.


'/>"/>
SOURCE Drug Production in Afghanistan: International Forum
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Still River Systems Announces Production Milestone for the Worlds Smallest High-Energy Proton Therapy Accelerator
2. Customer Elects to Forego Commercial Production of Product
3. Single-Use Sensor Product Family Enters High Volume Production
4. Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage
5. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
6. Worlds Only FDA Approved Home Needle Destruction Device is in Production
7. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
8. National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production
9. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
10. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  Ethicon* today ... Medical, Inc., a privately held medical device company ... System for the surgical treatment of Gastroesophageal Reflux ... strategy of expanding its portfolio of minimally invasive ... medical conditions. Financial terms of the transaction have ...
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 23, 2017  A new genetic test has ... of individuals who carry HLA-B*15:02 and ... yet potentially deadly side effect of certain medications ... gene HLA-B*15:02 is strongly associated with ... syndrome and toxic epidermal necrolysis in patients treated ...
Breaking Medicine Technology:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... of SmartBen NOW, an innovative mobile app and centralized benefits dashboard solving one ... critical information securely from multiple locations. For the first time, employees can access ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home ... world to manage stress and anxiety. , “Buzzies change the way we interact ... co-founder of Buzzies. , Since its launch date in December 2016, The TouchPoint Solution ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... According to the National ... sleep is likely not the only cause of the sunken-eye look, which can include ... look older or in poor health are likely due to genetics, dehydration, allergies, and ...
(Date:3/23/2017)... El Segundo, CA (PRWEB) , ... March 23, ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. ... primary source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are ...
Breaking Medicine News(10 mins):